Crescent Capital Consulting’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
LCM
DM
Crescent Capital Consulting's VTRS Position: Q4 2021 in Review
Crescent Capital Consulting increased its Viatris (VTRS) stake by 22% in Q4 2021, buying an estimated $15.1K and bringing the position to 6,169 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #245.
Crescent Capital Consulting first reported a position in VTRS in Q4 2020 and has held it in 5 quarters since. The position peaked at $95K in Q4 2020. 1,071 funds tracked by Wall St. Rank hold VTRS as of Q4 2021.
- Crescent Capital Consulting held 6,169 shares of Viatris worth $84K as of Q4 2021.
- Crescent Capital Consulting bought 1,129 Viatris shares in Q4 2021, an estimated $15.1K.
- Viatris made up 0.01% of Crescent Capital Consulting's portfolio in Q4 2021, its #245 holding.
- Crescent Capital Consulting first reported a position in Viatris in Q4 2020 and has held it in 5 quarters since.
- Crescent Capital Consulting's Viatris position peaked at $95K in Q4 2020.
- 1,071 funds tracked by Wall St. Rank held Viatris as of Q4 2021.
Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.